BlackRock acquired 132M Boston Scientific shares worth $6.44B. That's 0.10% of their equity portfolio (166th largest holding). The investor owns 3.67% of the outstanding Boston Scientific stock. The first Boston Scientific trade was made in Q4 2020. Since then BlackRock bought shares nine more times and sold shares on eight occasions. The stake costed the investor $5.73B, netting the investor a gain of 12% so far.
New York, New York--(Newsfile Corp. - April 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston ...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly ...
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Bosto...
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation (“Bosto...